Arrowhead Pharmaceuticals, Inc. SEC filings ARWR

Arrowhead Pharmaceuticals, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Apr 30, 2010. Its latest annual report, Form ARS, was filed on Jan 27, 2026 for the period ended Jan 26, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 4, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (material agreement, new debt). The company's fiscal year ends on September 30.

Arrowhead Pharmaceuticals, Inc. SEC filings
Form Description Filed Period
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 5, 2026 —
8-K Current report
Material agreement, New debt
Nov 4, 2026 Nov 4, 2026
4 Insider transaction Aug 20, 2026 Aug 18, 2026
4 Insider transaction Aug 20, 2026 Aug 18, 2026
144 Notice of proposed sale Aug 18, 2026 —
144 Notice of proposed sale Aug 18, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
8-K Current report
Results of operations
Aug 4, 2026 Aug 4, 2026
10-Q Quarterly report Aug 4, 2026 Jun 30, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 31, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 27, 2026 —
4 Insider transaction Jun 17, 2026 Jun 15, 2026
3 Initial insider ownership Jun 17, 2026 Jun 15, 2026
8-K Current report
Officer or director change
Jun 16, 2026 Jun 12, 2026
144/A Filing May 19, 2026 —
144/A Filing May 19, 2026 —
144/A Filing May 19, 2026 —
4 Insider transaction May 14, 2026 May 12, 2026
144 Notice of proposed sale May 12, 2026 —
S-8 Employee stock plan registration May 7, 2026 —
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
SCHEDULE 13G Ownership over 5% (passive) May 6, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Apr 29, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Apr 28, 2026 —
4 Insider transaction Apr 24, 2026 Apr 22, 2026
4 Insider transaction Apr 24, 2026 Apr 23, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 24, 2026 —
144 Notice of proposed sale Apr 23, 2026 —
144 Notice of proposed sale Apr 22, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
8-K Current report
Shareholder vote results
Mar 20, 2026 Mar 19, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
144 Notice of proposed sale Mar 5, 2026 —
10-Q Quarterly report Feb 5, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 5, 2026 Feb 5, 2026
ARS Annual report to shareholders Jan 27, 2026 Jan 26, 2026
DEFA14A Additional proxy material Jan 27, 2026 —
DEF 14A Proxy statement Jan 27, 2026 Jan 26, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 21, 2026 —
8-K Current report
Material agreement, New debt
Jan 12, 2026 Jan 12, 2026
8-K Current report
Material agreement, Other events
Jan 9, 2026 Jan 7, 2026
424B5 Prospectus supplement Jan 9, 2026 —
424B5 Prospectus supplement Jan 9, 2026 —
4 Insider transaction Jan 8, 2026 Jan 6, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
305B2 Filing Jan 8, 2026 —
FWP Free writing prospectus Jan 8, 2026 —
FWP Free writing prospectus Jan 8, 2026 —
424B5 Prospectus supplement Jan 7, 2026 —
424B5 Prospectus supplement Jan 7, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Jan 6, 2026 Jan 6, 2026
4 Insider transaction Jan 5, 2026 Dec 31, 2025
4 Insider transaction Jan 5, 2026 Jan 5, 2026
4 Insider transaction Jan 5, 2026 Jan 2, 2026
144/A Filing Jan 5, 2026 —
144 Notice of proposed sale Jan 5, 2026 —
144 Notice of proposed sale Jan 5, 2026 —
144 Notice of proposed sale Jan 2, 2026 —
4 Insider transaction Dec 30, 2025 Dec 29, 2025
4 Insider transaction Dec 30, 2025 Dec 26, 2025
144 Notice of proposed sale Dec 29, 2025 —
144 Notice of proposed sale Dec 29, 2025 —
4 Insider transaction Dec 23, 2025 Dec 19, 2025
4 Insider transaction Dec 23, 2025 Dec 19, 2025
4 Insider transaction Dec 23, 2025 Dec 19, 2025
4 Insider transaction Dec 23, 2025 Dec 19, 2025
144 Notice of proposed sale Dec 22, 2025 —
4 Insider transaction Dec 19, 2025 Dec 17, 2025
144 Notice of proposed sale Dec 19, 2025 —
144 Notice of proposed sale Dec 19, 2025 —
144 Notice of proposed sale Dec 19, 2025 —
144 Notice of proposed sale Dec 19, 2025 —
4 Insider transaction Dec 18, 2025 Dec 16, 2025
4 Insider transaction Dec 18, 2025 Dec 16, 2025
4 Insider transaction Dec 18, 2025 Dec 16, 2025
4 Insider transaction Dec 18, 2025 Dec 16, 2025
4 Insider transaction Dec 18, 2025 Dec 16, 2025
4 Insider transaction Dec 18, 2025 Dec 16, 2025
4 Insider transaction Dec 18, 2025 Dec 16, 2025
144 Notice of proposed sale Dec 17, 2025 —
144 Notice of proposed sale Dec 16, 2025 —
4 Insider transaction Dec 16, 2025 Dec 12, 2025
144 Notice of proposed sale Dec 15, 2025 —
S-3ASR Automatic shelf registration Dec 11, 2025 —
4 Insider transaction Dec 9, 2025 Dec 5, 2025
144 Notice of proposed sale Dec 5, 2025 —
4 Insider transaction Dec 1, 2025 Nov 28, 2025
144 Notice of proposed sale Nov 28, 2025 —
10-K Annual report Nov 25, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 25, 2025 Nov 25, 2025
8-K Current report
Other events
Nov 18, 2025 Nov 18, 2025
10-K/A Amended annual report Oct 10, 2025 Sep 30, 2024
4 Insider transaction Oct 3, 2025 Oct 1, 2025
144 Notice of proposed sale Oct 1, 2025 —
4 Insider transaction Sep 16, 2025 Sep 12, 2025
144 Notice of proposed sale Sep 12, 2025 —
8-K Current report
Other events
Sep 12, 2025 Sep 11, 2025
8-K Current report
Other events
Sep 11, 2025 Sep 10, 2025
4 Insider transaction Sep 4, 2025 Sep 2, 2025
144 Notice of proposed sale Sep 2, 2025 —
8-K Current report
Material agreement
Sep 2, 2025 Sep 2, 2025
4 Insider transaction Aug 15, 2025 Aug 13, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 15, 2025 —
144 Notice of proposed sale Aug 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
144 Notice of proposed sale Aug 13, 2025 —
144 Notice of proposed sale Aug 13, 2025 —
3 Initial insider ownership Aug 12, 2025 Apr 15, 2025
SCHEDULE 13G Ownership over 5% (passive) Aug 11, 2025 —
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 29, 2025 —
144 Notice of proposed sale Jul 10, 2025 —
SCHEDULE 13G Ownership over 5% (passive) May 13, 2025 —
8-K Current report
Results of operations
May 12, 2025 May 12, 2025
10-Q Quarterly report May 12, 2025 Mar 31, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 23, 2025 —
8-K Current report
Officer or director change
Apr 15, 2025 Apr 11, 2025
4 Insider transaction Apr 11, 2025 Apr 9, 2025
144 Notice of proposed sale Apr 11, 2025 —
144 Notice of proposed sale Apr 10, 2025 —
144 Notice of proposed sale Apr 9, 2025 —
8-K Current report
Shareholder vote results
Mar 19, 2025 Mar 12, 2025
4 Insider transaction Mar 17, 2025 Mar 13, 2025
144 Notice of proposed sale Mar 13, 2025 —
424B7 Filing Mar 7, 2025 —
4 Insider transaction Mar 5, 2025 Mar 3, 2025
144 Notice of proposed sale Mar 4, 2025 —
144 Notice of proposed sale Mar 3, 2025 —
SCHEDULE 13D Ownership over 5% (active) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
4 Insider transaction Feb 10, 2025 Feb 7, 2025
8-K Current report
Results of operations
Feb 10, 2025 Feb 10, 2025
10-Q Quarterly report Feb 10, 2025 Dec 31, 2024
4 Insider transaction Feb 7, 2025 Feb 6, 2025
3 Initial insider ownership Feb 7, 2025 Feb 6, 2025
DEFA14A Additional proxy material Feb 7, 2025 —
8-K Current report
Officer or director change
Feb 7, 2025 Feb 7, 2025
SCHEDULE 13G Ownership over 5% (passive) Feb 5, 2025 —
ARS Annual report to shareholders Jan 29, 2025 Jan 28, 2025
DEFA14A Additional proxy material Jan 29, 2025 —
DEF 14A Proxy statement Jan 29, 2025 Jan 28, 2025
4 Insider transaction Jan 27, 2025 Jan 23, 2025
144 Notice of proposed sale Jan 23, 2025 —
4 Insider transaction Jan 7, 2025 Jan 4, 2025
4 Insider transaction Jan 7, 2025 Jan 4, 2025
4 Insider transaction Jan 7, 2025 Jan 4, 2025
144 Notice of proposed sale Jan 7, 2025 —
144 Notice of proposed sale Jan 7, 2025 —
144 Notice of proposed sale Jan 7, 2025 —
4 Insider transaction Jan 6, 2025 Jan 2, 2025
144 Notice of proposed sale Jan 6, 2025 —
144 Notice of proposed sale Jan 6, 2025 —
144 Notice of proposed sale Jan 6, 2025 —
144 Notice of proposed sale Jan 6, 2025 —
144 Notice of proposed sale Jan 6, 2025 —
144 Notice of proposed sale Jan 6, 2025 —
144 Notice of proposed sale Jan 2, 2025 —
4 Insider transaction Dec 30, 2024 Dec 27, 2024
144 Notice of proposed sale Dec 27, 2024 —
4 Insider transaction Dec 23, 2024 Dec 23, 2024
144 Notice of proposed sale Dec 23, 2024 —
4 Insider transaction Dec 20, 2024 Dec 18, 2024
4 Insider transaction Dec 20, 2024 Dec 18, 2024
4 Insider transaction Dec 20, 2024 Dec 18, 2024
4 Insider transaction Dec 20, 2024 Dec 18, 2024
4 Insider transaction Dec 20, 2024 Dec 18, 2024
4 Insider transaction Dec 20, 2024 Dec 18, 2024
4 Insider transaction Dec 20, 2024 Dec 18, 2024
424B7 Filing Dec 20, 2024 —
4 Insider transaction Dec 18, 2024 Dec 16, 2024
4 Insider transaction Dec 18, 2024 Dec 16, 2024
4 Insider transaction Dec 18, 2024 Dec 16, 2024
144 Notice of proposed sale Dec 18, 2024 —
8-K Current report
Officer or director change
Dec 18, 2024 Dec 11, 2024
144 Notice of proposed sale Dec 17, 2024 —
144 Notice of proposed sale Dec 17, 2024 —
144 Notice of proposed sale Dec 16, 2024 —
144 Notice of proposed sale Dec 16, 2024 —
144 Notice of proposed sale Dec 16, 2024 —
8-K Current report
Results of operations
Nov 26, 2024 Nov 26, 2024
10-K Annual report Nov 26, 2024 Sep 30, 2024
5 Annual insider ownership Nov 15, 2024 Sep 30, 2024
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Oct 16, 2024 —
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
4 Insider transaction Jul 3, 2024 Jul 2, 2024
144 Notice of proposed sale Jul 2, 2024 —
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
10-Q Quarterly report May 9, 2024 Mar 31, 2024
4 Insider transaction May 6, 2024 May 2, 2024
144 Notice of proposed sale May 2, 2024 —
SC 13G/A Amended ownership over 5% (passive) Apr 10, 2024 —
4 Insider transaction Apr 3, 2024 Apr 1, 2024
144 Notice of proposed sale Apr 1, 2024 —
4 Insider transaction Mar 20, 2024 Mar 18, 2024
8-K Current report
Shareholder vote results
Mar 19, 2024 Mar 14, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ARWR (Nasdaq)
Fiscal year ends
September 30
Incorporated in
DE
Headquarters
Pasadena, CA
SEC filer status
Large accelerated filer
SEC CIK
879407
Former names
ARROWHEAD RESEARCH CORP (until Apr 6, 2016); INTERACTIVE GROUP INC (until Jan 9, 2004); INTERACTIVE INC (until Feb 13, 2002)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.